Volume 8, Number 8—August 2002
Research
Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus
Table 2
Variable | Odds ratio (95% CI) | p value |
---|---|---|
Main admitting disorder | 0.44 (0.28 to 0.68) | <0.001 |
Cardiovascular | 2.9 (1.5 to 5.7) | 0.002 |
Infectious | ||
Coexisting conditions | ||
Diabetes mellitus | 2.1 (1.5 to 3.1) | <0.001 |
Transplant recipient | 2.6 (1.6 to 4.5) | <0.001 |
Hepatobiliary disease | 2.9 (1.8 to 4.6) | <0.001 |
MRSA (in past yr) Clostridium difficile (in past yr) | 3.5 (1.8 to 6.9) 2.0 (0.97 to 4.3) | <0.001 0.06 |
CI, confidence interval; MRSA, methicillin-resistant Staphylococcus aureus.
Page created: July 16, 2010
Page updated: July 16, 2010
Page reviewed: July 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.